GAF domains are a large family of regulatory domains, and a subset are found associated with enzymes involved in cyclic nucleotide (cNMP) metabolism such as adenylyl cyclases and phosphodiesterases. CyaB2, an adenylyl cyclase from Anabaena, contains two GAF domains in tandem at the N-terminus and an adenylyl cyclase domain at the C-terminus.
Distinct binding modes and structural changes induced by cAMP and cGMP in the GAF domain of Anabaena adenylyl cyclase, CyaB2
GAF domains are a large family of regulatory domains, and a subset are found associated with enzymes involved in cyclic nucleotide (cNMP) metabolism such as adenylyl cyclases and phosphodiesterases. CyaB2, an adenylyl cyclase from Anabaena, contains two GAF domains in tandem at the N-terminus and an adenylyl cyclase domain at the C-terminus.
Cyclic AMP, but not cGMP, binding to the GAF domains of CyaB2 increases the activity of the cyclase domain leading to enhanced synthesis of cAMP. Here we show that the isolated GAFb domain of CyaB2 can bind both cAMP and cGMP, and enhanced specificity for cAMP is observed only when both the GAFa and the GAFb domains are present in tandem (GAFab domain). In silico docking and mutational analysis indicated distinct modes of binding of cAMP and cGMP to the GAFb domain. Structural changes associated with ligand binding to the GAF domains could not be detected by the highly sensitive Bioluminescence Resonance Energy Transfer (BRET) experiments. Amide hydrogen-deuterium exchange mass spectrometry (HDXMS) experiments, however, revealed the structural basis for cAMP-induced allosteric regulation of the GAF domains, and differences in the structural changes induced by cAMP and cGMP binding to the GAF domain. Thus, our results provide an insight into structural mechanisms of ligand binding to GAF domains in general, which can be utilized in developing molecules that modulate the allosteric regulation by GAF domains in pharmacologically relevant proteins. Although the sequences of these domains have diverged substantially due to their long 12 evolutionary history (Aravind et al. 2002) , a motif of five residues (NKFDE) is conserved in 13 most of the characterized cNMP-binding GAF domains (Zoraghi et al. 2004 ).
14
The structures of a number of cNMP-binding GAF domains have been solved by X-ray 15 crystallography and NMR. These include the GAF domains in the cGMP-stimulated, cAMP In the present study, we show by direct binding assays that the specificity of nucleotide binding 17 is reduced in an isolated GAF domain, as compared to the tandem GAFab domains of CyaB2. In EcoRV and XhoI sites, resulting in the generation of pGFP 2 -GAFab-Rluc plasmid.
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MATERIALS AND METHODS
1
Generation of various GAF domain constructs and mutagenesis
6
The nucleotide sequence encoding residues M1 to L431 was PCR amplified from the full-length 
Cyclic nucleotide binding assays
17
Cyclic nucleotide binding assays were carried out essentially as described earlier (Sopory et al. Blot analysis using an antibody raised in rabbit against the Rluc protein and described below. 
Generation of polyclonal antibody against Rluc
10
Polyclonal antibodies against Rluc protein was raised in rabbits using His6-Rluc protein 
HDXMS of the GAFb domain of CyaB2
5
The cAMP-free GAFb domain purified by size exclusion chromatography was concentrated to 6 50 μM using vivaspin concentrators (Sartorius Stedim Biotech GmbH, Goettingen, Germany). at 100 fmol/μl. We also visually analyzed the data to ensure only well resolved peptide isotopic 13 envelopes were subjected to quantitative analysis.
14
Statistical analysis
15
All experimental data were analyzed using GraphPad Prism and represent the mean ± S.E.M. results in a reduction in both affinity and specificity of nucleotide binding.
7
Cyclic GMP binds to the GAFb domain of CyaB2 in a mode distinct from that of cAMP 8 To gain insight into the mechanism by which cGMP could interact with the isolated GAFb domain, we performed in silico docking of cGMP on the structure of the GAFb domain. We (Fig. 2B) . Interestingly, the majority of the conformers were 19 found to interact with the GAFb domain in an orientation that was distinct from cAMP
20
(designated as mode 1) while only two conformers were found to interact in a mode that was 21 similar to crystal structure bound cAMP (designated as Mode 2) ( Fig. 2A & B) . Further, the 22 energy of interaction was lower for mode 1 conformers compared to mode 2 conformers. the mode of binding of cGMP was distinct from that seen for cAMP.
4
Analysis of the crystal structure of GAFb domain showed an interaction between the side chain 5 of I308 and the adenosine ring of cAMP (Martinez et al. 2005 ). An equivalent interaction is 6 found to be conserved in cyclic nucleotide binding GAF domains (Fig. 2C) . However, based on 7 our docking results, this interaction appears to be dispensable for cGMP binding, (Fig. 2A ). adenylyl cyclase domain (Fig. 1A) . We utilized BRET technology to determine if ligand binding We generated a fusion protein containing the GFP 2 protein at the N-terminal and Rluc protein to 4 the C-terminal (GAFb sensor) (Fig. 3A) . The GAFb sensor protein was expressed in HEK293T 5 cells and the expression was monitored by western blot analysis antibodies to Rluc (Fig. 3B ).
6
Lysates prepared from HEK293T cells expressing the GAFb sensor were incubated in the 7 absence or presence of 1 mM cAMP or cGMP, and BRET was measured. We used the F163A 8 mutant GAFa domain of PDE5, which binds both cAMP and cGMP, for the purpose of ( Fig. 3C) , indicating that the GAFb sensor expressed in mammalian cells is folded and could 11 potentially bind ligand. Importantly, unlike the PDE5 GAFa(F163A) sensor which showed an 12 increase in the BRET ratio in the presence of both cAMP and cGMP, no change in the BRET 13 ratio was observed for the GAFb sensor in the presence of either cAMP or cGMP (Fig. 3C ).
15
To rule out the requirement of any cellular factor for the induction of structural changes in the
16
GAF domain, we performed experiments with live cells expressing the GAFb sensor. these proteins were lower than that of the isolated GAFb domain (Fig. 3B) , and the basal BRET 7 of the constructs decreased in the order GAFb > GAFab > NterGAFab (Fig. 3C ). This change in 8 the basal BRET ratio suggested that we were able to detect spatial positioning of GFP 2 and Rluc 9 in the sensor constructs. However, incubation of lysates prepared from cells expressing either 10 the GAFab or the NterGAFab sensor with cAMP or cGMP (1 mM) also did not result in a 11 significant alteration in the BRET (Fig. 3C ).
12
Distinct changes in the dynamics of the GAFb domain of CyaB2 induced by cAMP and 13 cGMP binding 14 The lack of observable change in the BRET of the GAF domains of CyaB2 on ligand binding 15 was intriguing. We therefore decided to monitor more subtle structural changes in the GAFb 16 domain at a higher resolution using amide hydrogen/deuterium exchange mass spectrometry with >90% sequence coverage (Fig. 4) , thus providing a detailed overview of the solvent 21 accessibility and dynamics of the GAFb domain at peptide resolution. 
16
Importantly we show here that a low affinity ligand binds in a different mode, since mutation of 17 I308 only marginally reduced the affinity of binding of cGMP to the Cya GAFb domain (Fig.   18 2C).
19
The crystal structure of the cAMP-bound GAFb domain showed that cAMP is largely buried, terminal catalytic domain.
8
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